Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Candini

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Neurodevelopmental Disorders|November 26, 2024
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorderNicola Mottolese, Manuela Loi, Stefania Trazzi, et al.
Biomolecules|September 28, 2023
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency DisorderNicola Mottolese, Beatrice Uguagliati, Marianna Tassinari, et al.
Neurobiology of Disease|May 10, 2023
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorderMarianna Tassinari, Beatrice Uguagliati, Stefania Trazzi, et al.
International Journal of Molecular Sciences|July 29, 2025
Adult-Onset Deletion of CDKL5 in Forebrain Glutamatergic Neurons Impairs Synaptic Integrity and Behavior in MiceNicola Mottolese, Feliciana Iannibelli, Giulia Candini, et al.
International Journal of Molecular Sciences|August 12, 2022
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency DisorderMarianna Tassinari, Nicola Mottolese, Giuseppe Galvani, et al.
International Journal of Molecular Sciences|March 28, 2026
Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult <i>Cdkl5</i> KO MiceManuela Loi, Nicola Mottolese, Giorgio Medici, et al.
Frontiers in Bioengineering and Biotechnology|February 6, 2026
A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoidsGiorgio Medici, Angelica M Bove, Stefania Trazzi, et al.
International Journal of Molecular Sciences|March 13, 2025
Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency DisorderManuela Loi, Francesca Valenti, Giorgio Medici, et al.
Journal of Biological Engineering|July 17, 2025
Lactic acid bacteria as microbial cell factories for the in vivo delivery of therapeutic proteins as secretable TAT fusion productsGiorgio Medici, Giulia Candini, Nicola Mottolese, et al.
International Journal of Molecular Sciences|March 29, 2023
Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency DisorderManuela Loi, Stefano Bastianini, Giulia Candini, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Neurodevelopmental Disorders|November 26, 2024
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorderNicola Mottolese, Manuela Loi, Stefania Trazzi, et al.
Biomolecules|September 28, 2023
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency DisorderNicola Mottolese, Beatrice Uguagliati, Marianna Tassinari, et al.
Neurobiology of Disease|May 10, 2023
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorderMarianna Tassinari, Beatrice Uguagliati, Stefania Trazzi, et al.
International Journal of Molecular Sciences|July 29, 2025
Adult-Onset Deletion of CDKL5 in Forebrain Glutamatergic Neurons Impairs Synaptic Integrity and Behavior in MiceNicola Mottolese, Feliciana Iannibelli, Giulia Candini, et al.
International Journal of Molecular Sciences|August 12, 2022
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency DisorderMarianna Tassinari, Nicola Mottolese, Giuseppe Galvani, et al.
International Journal of Molecular Sciences|March 28, 2026
Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult <i>Cdkl5</i> KO MiceManuela Loi, Nicola Mottolese, Giorgio Medici, et al.
Frontiers in Bioengineering and Biotechnology|February 6, 2026
A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoidsGiorgio Medici, Angelica M Bove, Stefania Trazzi, et al.
International Journal of Molecular Sciences|March 13, 2025
Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency DisorderManuela Loi, Francesca Valenti, Giorgio Medici, et al.
Journal of Biological Engineering|July 17, 2025
Lactic acid bacteria as microbial cell factories for the in vivo delivery of therapeutic proteins as secretable TAT fusion productsGiorgio Medici, Giulia Candini, Nicola Mottolese, et al.
International Journal of Molecular Sciences|March 29, 2023
Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency DisorderManuela Loi, Stefano Bastianini, Giulia Candini, et al.
Pageof 2